SEC Comment Letter 0000000000-23-008170 to Zivo Bioscience, Inc. (ZIVO, ZIVOW) (CIK 0001101026) (ZIVO)
Zivo Bioscience, Inc. (ZIVO, ZIVOW) (CIK 0001101026)
Date: July 31, 2023 · CIK: 0001101026 · Accession: 0000000000-23-008170
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273493
Letter
United States securities and exchange commission logo July 31, 2023 Keith Marchiando Chief Financial Officer Zivo Bioscience, Inc. 21 East Long Lake Road, Suite 100 Bloomfield Hills, Michigan 48304 Re:Zivo Bioscience, Inc. Registration Statement on Form S-3 Filed July 28, 2023 File No. 333-273493 Dear Keith Marchiando: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey H. Kuras
Show Raw Text
United States securities and exchange commission logo
July 31, 2023
Keith Marchiando
Chief Financial Officer
Zivo Bioscience, Inc.
21 East Long Lake Road, Suite 100
Bloomfield Hills, Michigan 48304
Re:Zivo Bioscience, Inc.
Registration Statement on Form S-3
Filed July 28, 2023
File No. 333-273493
Dear Keith Marchiando:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jeffrey H. Kuras